Roche Defends Accutane Against New Evidence In NJ Retrial

Law360, New York (March 7, 2014, 8:57 PM EST) -- Hoffman-LaRoche Inc. on Friday urged a New Jersey jury to reject claims its drug Accutane causes inflammatory bowel disease, summating a case that was buttressed by new scientific evidence following an appellate reversal of a $10 million verdict awarded to the plaintiff in 2008.

Orlando R. Richmond of Butler Snow LLP, an attorney for Roche, told a New Jersey state jury that the evidence it heard in more than a month of testimony does not establish a causal connection between Roche’s Accutane and the ulcerative colitis...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.